Contact: Mimi Grant, President of ABL Organization
207 E. Memory Lane  Santa Ana, CA 92705
Phone: (714) 245-2400  

Daniel Kraft, MD, named ABL’s 2011 “Leadership in Innovation” Awardee

Kraft will also Keynote ABL's 13th Annual Innovations in HealthcareSM Awards Event, September 28

Santa Ana, CA - July 19, 2011 - Daniel Kraft, MD, among the nation’s most prolific, multi-dimensional, and “applied healthcare" futurists, will receive the Adaptive Business Leaders Organization (ABL)’s 2011 “Leadership in Innovation” Award and make the Keynote Presentation at ABL's 13th Annual Innovations in HealthcareSM Awards Event, on September 28, in Long Beach, California.

A Stanford- and Harvard-trained physician-scientist with over 20 years of experience in clinical practice, biomedical research, and healthcare innovation, Daniel is a serial entrepreneur, who is also an educator, inventor/developer of medical devices, drug therapies, and telecommunications systems. Currently, Daniel is the Founder and CEO of IntelliMedicine, which focuses on enabling connected, data-driven, and integrated personalized medicine. He also chairs the Medicine Track for Singularity University and is Executive Director of its FutureMed Program, which educates, informs, and prepares physicians and senior healthcare executives to understand and recognize the opportunities and disruptive influences of exponentially growing technologies within medicine and healthcare, and to understand how many rapidly developing and converging fields affect the future of clinical practice and the biomedical industry.

Daniel is also a Venture Partner with Proteus Venture Partners, and has served as an advisor to CollabRx (personalized oncology), Wellsphere (general health and wellness), Cepheid (point-of-care diagnostics), and the X Prize Foundation (life sciences). He invented the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. He built the first Internet-based alphanumeric paging system at the Stanford hospitals to facilitate communication between clinical staff. In research at the National Institutes of Health, Daniel conceived of and demonstrated proof of concept for a monoclonal antibody-based therapy for treating allergic disease; his general approach was later translated to an antibody Xolair therapeutic by Genentech.  

In accepting ABL’s “Leadership” Award, Daniel joins the impressive circle of ABL’s previous “Leadership in Innovation” Awardees. In 2010, the Award went to Debra Reisenthel, founding CEO and dynamic leader of Novasys Medical; in 2009, Patrick Soon-Shiong, visionary philanthropist and founder of Abraxis Bioscience and Health, received the Award; in 2008, Steve Case, founder of Revolution Health and AOL, was honored; in 2007, Steve Burd, CEO and chief wellness advocate of Safeway Inc.; in 2006, Ken Kizer, MD, visionary behind the VA’s VistA Electronic Medical Record System, as the U.S. Dept of Veterans Affairs’ Under Secretary for Health; in 2005, Kent Thiry, CEO of DaVita, an innovative provider of health education and dialysis services; and in 2004, Leonard Schaeffer, CEO of WellPoint Health Networks, one of the nation’s largest health plans, became the first Awardee.

Also at the September 28 Innovations in HealthcareSM Event, “ABBY Awards” will be presented to four companies, chosen from among 12 that will present their innovative approaches to either the delivery of healthcare, health information and telecommunications technologies, or innovative medical devices. These 12 Finalists were selected for best meeting ABL’s criteria of having an innovative product and/or service that is used in the U.S., with clinical and financial metrics that prove its technology or approach reduces the cost of providing quality healthcare. ABBY Award Winners will be selected via secret ballot by Event attendees, after viewing presentations made by each Finalist company’s CEO.

Now in its 13th year, ABL’s Innovations in HealthcareSM Awards Event recognizes organizations that have demonstrated transformative advances in enabling quality healthcare at a lower cost, resulting in better care, and healthcare consumers who are more actively engaged in their care and health status. Details about the Innovations in HealthcareSM Awards Event can be found at http://www.abl.org/IIH.htm.

About the Adaptive Business Leaders (ABL) Organization
ABL supports the needs of its Member CEOs by providing a place for top-level executives to draw on the experience, knowledge and skill sets of their healthcare and technology industry peers in a vertical industry, personal advisory board setting. Members meet monthly in Round Tables, as well as in frequent workshops and conferences, to hear from cutting-edge experts, to exchange ideas, and connect with other chief executives. ABL's CEO Round Table program is offered throughout California: in Greater Los Angeles, Orange, San Diego, San Francisco, and Santa Clara Counties. More information can be found at http://www.abl.org and http://www.abl.org/IIH.htm.  

Laura Grant, Events Director, at 714/245-1427, or Mimi Grant, President, at 714/245-1425


website statistics